Search
Search Results
##search.searchResults.foundPlural##
-
HIV INFECTION, ANTIRETROVIRAL THERAPY AND CARDIOVASCULAR RISK
1791PDF: 791HTML: 3589 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7379PDF: 2401HTML: 1714Table 1.: 199Table 2.: 212Table 3.: 192Table 4.: 192 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3283PDF: 1228HTML: 2188 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
2870PDF: 1575HTML: 222 -
ADVANCED HODGKIN LYMPHOMA: A NEW ERA OF THERAPY
2110PDF: 1316HTML: 3492 -
UPDATE ON THE LABORATORY DIAGNOSIS OF INVASIVE FUNGAL INFECTIONS
2344PDF: 1384HTML: 1971 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
1808HTML: 1414PDF: 1064 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4197PDF: 1510HTML: 437 -
FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT
4383PDF: 1614HTML: 3571Tables and Images: 210 -
THALASSEMIA AND VENOUS THROMBOEMBOLISM
2894PDF: 1014HTML: 4570 -
Guest Editor: G. Castaman AGING WITH HEMOPHILIA: THE CHALLENGE OF APPROPRIATE DRUG PRESCRIPTION Hemophilia and aging
1649PDF: 1429HTML: 237 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
3880PDF: 1477HTML: 9178Untitled: 270Untitled: 175Untitled: 161Untitled: 157Untitled: 173Untitled: 330 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3653PDF: 1229HTML: 3873Untitled: 203Untitled: 254 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1021PDF: 956HTML: 314 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4685PDF: 1541HTML: 2243Untitled: 201Untitled: 217Untitled: 226Untitled: 208Untitled: 209 -
LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.
3676PDF: 1076HTML: 2274Figure 1: 205 -
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1378PDF: 793HTML: 302 -
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
6774PDF: 3629HTML: 746 -
Successful treatment with eltrombopag in avoiding splenectomy for patients with chronic refractory immune thrombocytopenia
1326PDF: 800HTML: 1015Untitled: 181 -
Zika virus infection - Proposed Management Strategies
1914PDF: 742HTML: 494 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
822PDF: 485HTML: 1292 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
809PDF: 536HTML: 4008 -
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
4610PDF: 1305HTML: 1900Untitled: 177Untitled: 173 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5103PDF: 1311HTML: 2735Cover letter: 187







